发明名称 Mullerian inhibiting substance levels and ovarian response
摘要 Methods and kits are provided for assessing the ovarian reserve and predicting the ovarian response to fertility treatments in a female subject. The serum levels of MIS are shown to be positively correlated with the production and retrieval of mature oocytes and serve as prognostic indicators for the female response to fertility treatment. The MIS levels can be monitored prior to and during fertility treatment and are useful to adjust the timing and dosage of treatments in order to produce optimal outcome in individual patients, to avoid ovarian hyperstimulation, or to indicate cancellation of an unsuccessful treatment. MIS can also be administered to women to stimulate follicle development and to prevent depletion of ovarian reserve.
申请公布号 US7241577(B2) 申请公布日期 2007.07.10
申请号 US20020225503 申请日期 2002.08.20
申请人 THE GENERAL HOSPITAL CORPORATION 发明人 SEIFER DAVID B.;MACLAUGHLIN DAVID T.
分类号 G01N33/53;A61K38/22;A61P15/08;C07K14/00;G01N33/68 主分类号 G01N33/53
代理机构 代理人
主权项
地址